Lpl Financial LLC Replimune Group, Inc. Transaction History
Lpl Financial LLC
- $320 Billion
- Q3 2025
A detailed history of Lpl Financial LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 19,584 shares of REPL stock, worth $176,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,584
Previous 16,344
19.82%
Holding current value
$176,060
Previous $151,000
45.7%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding REPL
# of Institutions
192Shares Held
80.4MCall Options Held
8.69MPut Options Held
2.28M-
Baker Bros. Advisors LP New York, NY11MShares$99.3 Million0.38% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.31MShares$74.7 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.4MShares$57.5 Million0.36% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$42.4 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.16MShares$37.4 Million3.48% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $443M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...